MiniMed Group Inc (NASDAQ:MMED – Get Free Report)’s stock price gapped up before the market opened on Monday. The stock had previously closed at $17.99, but opened at $18.83. MiniMed Group shares last traded at $18.7430, with a volume of 1,355,346 shares traded.
Analysts Set New Price Targets
Several equities analysts have recently commented on the company. Truist Financial initiated coverage on MiniMed Group in a research report on Thursday, September 24th. They issued a “buy” rating and a $29.00 target price on the stock. BTIG Research boosted their price target on MiniMed Group from $25.00 to $28.00 and gave the company a “buy” rating in a research note on Tuesday, September 1st. Weiss Ratings raised MiniMed Group from a “sell (d-)” rating to a “sell (d)” rating in a report on Wednesday, September 9th. UBS Group increased their price objective on MiniMed Group from $25.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Finally, Mizuho lifted their target price on MiniMed Group from $26.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. Fourteen investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, MiniMed Group currently has an average rating of “Moderate Buy” and a consensus target price of $24.12.
View Our Latest Research Report on MMED
MiniMed Group Price Performance
The business’s 50-day moving average price is $19.61 and its two-hundred day moving average price is $16.73. The company has a market capitalization of $5.27 billion and a price-to-earnings ratio of -27.47.
Hedge Funds Weigh In On MiniMed Group
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MMED. Parkside Financial Bank & Trust bought a new stake in MiniMed Group during the second quarter worth about $28,000. Boston Partners increased its holdings in MiniMed Group by 0.6% in the 3rd quarter. Boston Partners now owns 908,007 shares of the company’s stock valued at $17,695,000 after buying an additional 5,648 shares during the period. Legal & General Group Plc acquired a new position in shares of MiniMed Group in the 2nd quarter valued at approximately $91,000. State of Wyoming acquired a new position in shares of MiniMed Group in the 3rd quarter valued at approximately $167,000. Finally, State of Alaska Department of Revenue bought a new stake in shares of MiniMed Group during the 3rd quarter worth approximately $227,000.
About MiniMed Group
MiniMed Group focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery. The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care.
Recommended Stories
- Five stocks we like better than MiniMed Group
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.
